stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / IART / Net Income

Integra LifeSciences Holdings Corporation Net Income 2008–2025

Integra LifeSciences Holdings Corporation (IART) annual net income by fiscal year, computed from SEC filings.

Fiscal yearNet IncomeNet marginChange (YoY)
FY 2025$-516.47M-31.6%-7337.7%
FY 2024$-6.94M-0.4%-110.3%
FY 2023$67.74M4.4%-62.5%
FY 2022$180.55M11.6%+6.8%
FY 2021$169.07M11.0%+26.3%
FY 2020$133.89M9.8%+166.7%
FY 2019$50.20M3.3%-17.4%
FY 2018$60.80M4.1%-6.1%
FY 2017$64.74M5.4%-13.2%
FY 2016$74.56M7.5%+2218.9%
FY 2015$-3.52M-110.3%
FY 2014$34.00M+261.4%
FY 2013$-21.07M-151.1%
FY 2012$41.20M+47.2%
FY 2011$27.99M-57.4%
FY 2010$65.67M+28.9%
FY 2009$50.95M+83.8%
FY 2008$27.73M

Source: Integra LifeSciences Holdings Corporation SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Integra LifeSciences Holdings Corporation

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Integra LifeSciences Holdings Corporation — frequently asked questions

What is Integra LifeSciences Holdings Corporation's net income?

Integra LifeSciences Holdings Corporation (IART) reported net income of $-516.47M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from Integra LifeSciences Holdings Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More IART financial history

Full IART fundamentals page → · All 1,500+ companies →